Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$12.18 USD
-0.25 (-2.01%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $12.18 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TNDM 12.18 -0.25(-2.01%)
Will TNDM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNDM
TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say
TNDM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
Bears are Losing Control Over Tandem Diabetes Care (TNDM), Here's Why It's a 'Buy' Now
Other News for TNDM
Leerink says removal of C-peptide requirement would benefit pump market, Tandem
Leerink says removal of C-peptide requirement would benefit pump market, Tandem
20 Day Moving Average Support appears for TNDM after 2.81% move
Tandem Diabetes (TNDM) Study Highlights Benefits of Control-IQ+ System for Type 2 Diabetes
Tandem Diabetes announces publication of 2IQP study in Diabetes Care